- Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research
-
Lee SJ, Yang A, Wu TC, Hung CF
- KMID: 2374253
- J Gynecol Oncol.
- 2016 Sep;27(5):e51.
- doi: 10.3802/jgo.2016.27.e51
Cervical cancer is the fourth most lethal women's cancer worldwide. Current treatments against cervical cancer include surgery, radiotherapy, chemotherapy, and anti-angiogenic agents. However, despite the various treatments utilized for the... -
- CITED
-
- Close
- SHARE
-
- Close
- Identificaiton of Novel Immunogenic Human Papillomavirus Type 16 E7-Specific Epitopes Restricted to HLA-A*33;03 for Cervical Cancer Immunotherapy
-
Kim S, Chung HW, Kong HY, Lim JB
- KMID: 2374187
- Yonsei Med J.
- 2017 Jan;58(1):43-50.
- doi: 10.3349/ymj.2017.58.1.43
PURPOSE: To identify new immunogenic HLA-A*33;03-restricted epitopes from the human papillomavirus (HPV) 16 E7 protein for immunotherapy against cervical cancer. MATERIALS AND METHODS: We synthesized fourteen overlapping 15-amino acid peptides and... -
- CITED
-
- Close
- SHARE
-
- Close
